Artivion Inc
NYSE:AORT 12:32:51 AM EDT
| Market Cap (Intraday) | 826.67M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 198.2 |
| 10-Day MA | $20.46 |
| 50-Day MA | $20.14 |
| 200-Day MA | $17.18 |
Artivion Inc Stock, NYSE:AORT
1655 Roberts Boulevard NW, Kennesaw, Georgia 30144-3632
United States of America
Phone: +1.770.419.3355
Number of Employees: 1500
Description
Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.